Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-12-2014 | Research

A mathematical model of seropositivity to malaria antigen, allowing seropositivity to be prolonged by exposure

Author: Samuel Bosomprah

Published in: Malaria Journal | Issue 1/2014

Login to get access

Abstract

Background

Malaria transmission intensity is traditionally estimated from entomological studies as the entomological inoculation rate (EIR), but this is labour intensive and also raises sampling issues due to the large variation from house to house. Incidence of malaria in the control group of a trial or in a cohort study can be used but is difficult to interpret and to compare between different places and between age groups because of differences in levels of acquired immunity. The reversible catalytic model has been developed to estimate malaria transmission intensity using age-stratified serological data. However, the limitation of this model is that it does not allow for persons to have their seropositivity boosted by exposure while they are already seropositive. The aim of this paper is to develop superinfection mathematical models that allow for antibody response to be boosted by exposure.

Method

The superinfection models were fitted to age-stratified serological data using maximum likelihood method.

Results

The results showed that estimates of seroconversion rate were higher using the superinfection model than catalytic model. This difference was milder when the level of transmission was lower. This suggests that the catalytic model is underestimating the transmission intensity by up to 31%. The duration of seropositivity is shorter with superinfection model, but still seems too long.

Conclusion

The model is important because it can produce more realistic estimates of the duration of seropositivity. This is analogous to Dietz model, which allowed for superinfection and produced more realistic estimates of the duration of infection as compared to the original Ross-MacDonald malaria model, which also ignores superinfection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Muench H: Catalytic models in epidemiology. 1959, Cambridge, Mass: Harvard University PressCrossRef Muench H: Catalytic models in epidemiology. 1959, Cambridge, Mass: Harvard University PressCrossRef
2.
go back to reference Anderson RM, May RM: Directly transmitted infections diseases: control by vaccination. Science. 1982, 215: 1053-1060. 10.1126/science.7063839.CrossRefPubMed Anderson RM, May RM: Directly transmitted infections diseases: control by vaccination. Science. 1982, 215: 1053-1060. 10.1126/science.7063839.CrossRefPubMed
3.
go back to reference Griffiths DA: A catalytic model of infection for measles. Appl Stat. 1974, 23: 330-339. 10.2307/2347126.CrossRef Griffiths DA: A catalytic model of infection for measles. Appl Stat. 1974, 23: 330-339. 10.2307/2347126.CrossRef
4.
go back to reference Remme J, Mandara MP, Leeuwenburg J: The force of measles infection in East Africa. Int J Epidemiol. 1984, 13: 332-339. 10.1093/ije/13.3.332.CrossRefPubMed Remme J, Mandara MP, Leeuwenburg J: The force of measles infection in East Africa. Int J Epidemiol. 1984, 13: 332-339. 10.1093/ije/13.3.332.CrossRefPubMed
5.
go back to reference Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM: Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005, 102: 5108-5113. 10.1073/pnas.0408725102.PubMedCentralCrossRefPubMed Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM: Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A. 2005, 102: 5108-5113. 10.1073/pnas.0408725102.PubMedCentralCrossRefPubMed
6.
go back to reference Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, Riley EM, Drakeley CJ: Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One. 2011, 6: e25137-10.1371/journal.pone.0025137.PubMedCentralCrossRefPubMed Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, Riley EM, Drakeley CJ: Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One. 2011, 6: e25137-10.1371/journal.pone.0025137.PubMedCentralCrossRefPubMed
7.
go back to reference Bailey NTJ: The mathematical theory of epidemics. 1957, London: Griffin, 157-159. Bailey NTJ: The mathematical theory of epidemics. 1957, London: Griffin, 157-159.
8.
go back to reference Bailey NTJ: The biomathematics of malaria. 1982, London: Charles Griff Bailey NTJ: The biomathematics of malaria. 1982, London: Charles Griff
9.
go back to reference Milligan P, Downham DY: Models of superinfection and acquired immunity to multiple parasite strains. J Appl Probab. 1996, 33: 915-932. 10.2307/3214973.CrossRef Milligan P, Downham DY: Models of superinfection and acquired immunity to multiple parasite strains. J Appl Probab. 1996, 33: 915-932. 10.2307/3214973.CrossRef
10.
go back to reference Nasell I: On superinfection in malaria. Math Med Biol. 1986, 3: 211-227. 10.1093/imammb/3.3.211.CrossRef Nasell I: On superinfection in malaria. Math Med Biol. 1986, 3: 211-227. 10.1093/imammb/3.3.211.CrossRef
11.
go back to reference Bailey NTJ: The elements of stochastic processes with applications to the natural sciences. 1990, John Wiley & Sons, 13: 978-0-471-52368-0 Bailey NTJ: The elements of stochastic processes with applications to the natural sciences. 1990, John Wiley & Sons, 13: 978-0-471-52368-0
12.
go back to reference Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C: Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009, 4: e6083-10.1371/journal.pone.0006083.PubMedCentralCrossRefPubMed Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, Masika P, Mosha J, Bousema T, Shekalaghe S, Cook J, Corran P, Ghani A, Riley EM, Drakeley C: Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009, 4: e6083-10.1371/journal.pone.0006083.PubMedCentralCrossRefPubMed
13.
go back to reference Gould W, Pitblado J, Poi B: Maximum likelihood estimation with stata. 2010, 4905 Lakeway Drive, College Station, Texas 77485: Stata Press, 4 Gould W, Pitblado J, Poi B: Maximum likelihood estimation with stata. 2010, 4905 Lakeway Drive, College Station, Texas 77485: Stata Press, 4
14.
go back to reference Macdonald G: The analysis of the sporozoite rate. Trop Dis Bull. 1952, 49: 569-586.PubMed Macdonald G: The analysis of the sporozoite rate. Trop Dis Bull. 1952, 49: 569-586.PubMed
16.
go back to reference Macdonald G: The epidemiology and control of malaria. 1957, London: Oxford University Press Macdonald G: The epidemiology and control of malaria. 1957, London: Oxford University Press
17.
go back to reference Ross R: The prevention of malaria. 1911, London: Murray, 2 Ross R: The prevention of malaria. 1911, London: Murray, 2
18.
go back to reference Bødker R, Akida J, Shayo D, Kisinza W, Msangeni HA, Pedersen EM, Lindsay SW: Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J Med Entomol. 2003, 40: 706-717. 10.1603/0022-2585-40.5.706.CrossRefPubMed Bødker R, Akida J, Shayo D, Kisinza W, Msangeni HA, Pedersen EM, Lindsay SW: Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J Med Entomol. 2003, 40: 706-717. 10.1603/0022-2585-40.5.706.CrossRefPubMed
19.
go back to reference Akpogheneta OJ, Duah NO, Tetteh KKA, Dunyo S, Lanar DE, Pinder M, Conway DJ: Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun. 2008, 76: 1748-1755. 10.1128/IAI.01333-07.PubMedCentralCrossRefPubMed Akpogheneta OJ, Duah NO, Tetteh KKA, Dunyo S, Lanar DE, Pinder M, Conway DJ: Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun. 2008, 76: 1748-1755. 10.1128/IAI.01333-07.PubMedCentralCrossRefPubMed
20.
go back to reference Portugal S, Carret C, Recker M, Armitage AE, Gonçalves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM: Host-mediated regulation of superinfection in malaria. Nat Med. 2011, 17: 732-737. 10.1038/nm.2368.PubMedCentralCrossRefPubMed Portugal S, Carret C, Recker M, Armitage AE, Gonçalves LA, Epiphanio S, Sullivan D, Roy C, Newbold CI, Drakesmith H, Mota MM: Host-mediated regulation of superinfection in malaria. Nat Med. 2011, 17: 732-737. 10.1038/nm.2368.PubMedCentralCrossRefPubMed
Metadata
Title
A mathematical model of seropositivity to malaria antigen, allowing seropositivity to be prolonged by exposure
Author
Samuel Bosomprah
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-12

Other articles of this Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine